Manufacturer
NOVARTIS PHARMA STEIN AG
Contents
Letrozole
Indication
Adjuvant treatment in early breast cancer, Advanced or locally advanced breast cancer
Instruction
May be taken with or without food.
Drug interaction
Tamoxifen, anti-oestrogen agent, oestrogen-containing drugs may diminish the pharmacological action of letrozole. Decreased plasma concentration w/ strong CYP3A4 inducers (e.g. rifampicin).
NOVARTIS PHARMA STEIN AG
Contents
Letrozole
Indication
Adjuvant treatment in early breast cancer, Advanced or locally advanced breast cancer
Instruction
May be taken with or without food.
Drug interaction
Tamoxifen, anti-oestrogen agent, oestrogen-containing drugs may diminish the pharmacological action of letrozole. Decreased plasma concentration w/ strong CYP3A4 inducers (e.g. rifampicin).
Inquiry - Femara 2.5 mg Film-Coated Tablet